AstraZeneca is to buy out its joint venture with Bristol-Myers Squibb in a deal worth up to $4.3 billion, as it seeks to strengthen its limited range of innovative products and become a leading supplier of diabetes medicines

AstraZeneca is to buy out its joint venture with Bristol-Myers Squibb in a deal worth up to $4.3 billion, as it seeks to strengthen its limited range (...)

Amgen employs about 250 people in Dublin in two sites in Dun Laoghaire andSantry.

US pharmaceutical group Amgen is to acquire Onyx Pharmaceuticals in a $10.4 billion (€7.8bn) deal that gives Amgen access to a rapidly expanding cance(...)